Effects of 12 mg vs. 6 mg dexamethasone on thromboembolism and bleeding in patients with critical COVID-19 - a post hoc analysis of the randomized, blinded COVID STEROID 2 trial

Effects of 12 mg vs. 6 mg dexamethasone on thromboembolism and bleeding in patients with critical COVID-19 - a post hoc analysis of the randomized, blinded COVID STEROID 2 trial

Abstract Background Thromboembolism is more common in patients with critical COVID-19 than in other critically ill patients, and inflammation has been proposed as a possible mechanism. The aim of this study was to investigate if 12 mg vs. 6 mg dexamethasone daily reduced the composite outcome of dea...

Full description

Bibliographic Details
Main Authors: Sandra Jonmarker, Felix Alarcón, Jacob Litorell, Anders Granholm, Eva Joelsson Alm, Michelle Chew, Lene Russell, Sarah Weihe, Emilie Kabel Madsen, Nick Meier, Jens Wolfgang Leistner, Johan Mårtensson, Jacob Hollenberg, Anders Perner, Maj-Brit Nørregaard Kjær, Marie Warrer Munch, Martin Dahlberg, Maria Cronhjort, Rebecka Rubenson Wahlin
Format: Article
Language:English
Published: SpringerOpen 2023-03-01
Series:Annals of Intensive Care
Subjects:
COVID-19
Glucocorticoids
Steroids
Intensive care
Thrombosis
Thromboembolism
Online Access:https://doi.org/10.1186/s13613-023-01115-y

Internet

https://doi.org/10.1186/s13613-023-01115-y

Similar Items